首页> 外文期刊>Cancer Management and Research >LncRNA DCST1-AS1 Sponges miR-107 to Upregulate CDK6 in Cervical Squamous Cell Carcinoma
【24h】

LncRNA DCST1-AS1 Sponges miR-107 to Upregulate CDK6 in Cervical Squamous Cell Carcinoma

机译:LNCRNA DCST1-AS1海绵MIR-107在宫颈鳞状细胞癌中上调CDK6

获取原文
获取外文期刊封面目录资料

摘要

Introduction: LncRNAs have been reported to play critical roles in liver cancer, while its role in other cancers remains unclear. The aim of this study was to investigate the role of DCST1-AS1 in cervical squamous cell carcinoma (CSCC). Methods: Expression of DCST1-AS1 in CSCC tissues and non-tumor tissues from 68 CSCC patients was determined by RT-qPCR. A 5-year follow-up study was carried out to explore the prognostic value of DCST1-AS1 for CSCC. Overexpression of DCST1-AS1 and miR-107 was achieved in CSCC tissues to explore the interaction between them. The roles of DCST1-AS1, miR-107 and CDK6 in regulating the proliferation and viability of CSCC cells were assessed by cell proliferation and viability assays, respectively. Results: We found that DCST1-AS1 was upregulated in CSCC and predicted poor survival. RNA interaction prediction showed potential interaction between DCST1-AS1 and miR-107. However, overexpression experiments revealed no significant interaction between them. Moreover, overexpression of DCST1-AS1 led to upregulate CDK6 and increase cell proliferation rate, while overexpression of miR-107 played an opposite role and attenuate the effects of overexpression of DCST1-AS1. Conclusion: DCST1-AS1 may sponge miR-107 to upregulate CDK6 in CSCC.
机译:介绍:据报道,LNCRNA在肝癌中发挥关键作用,而其在其他癌症中的作用仍不清楚。本研究的目的是探讨DCST1-AS1在宫颈鳞状细胞癌(CSCC)中的作用。方法:通过RT-QPCR测定来自68名CSCC患者的CSCC组织和非肿瘤组织中DCST1-AS1的表达。进行了5年的后续研究,以探讨CSCC的DCST1-AS1的预后价值。在CSCC组织中实现了DCST1-AS1和MIR-107的过表达,以探索它们之间的相互作用。通过细胞增殖和活力测定分别评估DC​​ST1-AS1,MIR-107和CDK6在调节CSCC细胞的增殖和活力方面的作用。结果:我们发现DCST1-AS1在CSCC中上调并预测存活率差。 RNA相互作用预测显示DCST1-AS1和MIR-107之间的潜在相互作用。然而,过表达实验显示它们之间没有显着的相互作用。此外,DCST1-AS1的过度表达LED上调了CDK6并增加了细胞增殖率,而MIR-107的过度表达起作用了相反的作用并衰减过表达DCST1-AS1的影响。结论:DCST1-AS1可以将MIR-107海绵上调,以在CSCC中上调CDK6。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号